XNCR - Xencor, Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
12.43 1.81 (14.56%)	---	---	---	0.03 (0.24%)	1.52 (12.08%)	0.0 (0.0%)	0.0 (0.0%)

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.41
Diluted EPS:: -0.41
Basic P/E:: -34.7317
Diluted P/E:: -34.7317
RSI(14) 1m:: 100.0
VWAP:: 14.24
RVol:: 0.9007

Events

Period	Kind	Movement	Occurred At
60m	Price increase 60m	13.1 +0.63 (+5.1%)	Oct 15 09:54
1m	Price increase 1m	13.07 +0.14 (+1.08%)	Oct 15 09:50
1m	Price increase 1m	13.07 +0.23 (+1.79%)	Oct 15 09:44
10m	Price increase 10m	13.07 +0.38 (+3.04%)	Oct 15 09:44
1m	Price decrease 1m	12.59 -0.13 (-1.02%)	Oct 15 09:37